This report summarizes current (as of 2011) guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons ...

Synthesizes findings on the dual challenges of women drug users: greater vulnerability to sexually and injection-transmitted HIV infection and less access to services than men. Makes recommendations on outreach, testing, treatment, care, and policy.

The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral (ARV) drugs recommended by the World Health Organization (WHO). It links this information with an analysis of the intellectual property situation of the selected ARV medicines ...

How do intellectual property rights affect access to HIV medicines and other health technologies? This document provides a review of key issues related to intellectual property policies and their potential impact on access to HIV and other medicines. It is intended as an introduction to the ...

Thirty years into the AIDS epidemic, leaders came together at the 2011 United Nations General Assembly High Level Meeting on AIDS from 8–10 June 2011 in New York. The Political Declaration emerging from this meeting, while appreciating the “substantial progress over the three decades since ...

HIV testing in presumptive & diagnosed TB cases is effective at identifying PLHIV & saving lives in all settings Reaching the first 90%, will help to diagnose 90% of HIV-related TB. Co-location and integration facilitates scale-up and increases access in both generalized and concentrated ...